Scientist
Sangamo Therapeutics
Brisbane, California
Dr. Jing Hu received her PhD in Pharmaceutical Sciences from University of Cincinnati in 2015. She is currently a Scientist in Biomarker and BioAnalytical Sciences group at Sangamo Therapeutics. Her responsibilities include defining bioanalytical strategies and performing assay development and qualification for gene therapy programs, including biomarker and immunogenicity assay. Prior to joining Sangamo, Dr. Hu worked in the department of Biochemical & Cellular Pharmacology in Genentech and focused on assay development and sample testing for PK/PD analysis of preclinical studies in Neurodegeneration disease area.
Disclosure information not submitted.
Tuesday, October 18, 2022
3:45 PM – 4:00 PM ET